Wendy Hill
Adult Health · Penn Yan, NYNPI 1821107517
Payments from drug & device makers
Across 258 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$810
- Novo Nordisk$808
- Amgen$657
- Pfizer$477
- GSK$273
- Lilly USA, LLC$267
- plus $2K from 27 others
What the payments were for
- Consulting fees$1753%
- Food & beverage$4,89997%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 33 | $810 |
| Novo Nordisk | 39 | $808 |
| Amgen | 28 | $657 |
| Pfizer | 30 | $477 |
| GSK | 18 | $273 |
| Lilly USA, LLC | 14 | $267 |
| Astellas Pharma US Inc | 16 | $222 |
| Boehringer Ingelheim | 11 | $216 |
| Exact Sciences | 10 | $193 |
| Bayer | 10 | $189 |
| AbbVie | 7 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $114 |
| Amarin Pharma, Inc. | 4 | $80 |
| Sanofi-aventis U.S. LLC | 3 | $73 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $63 |
| Corcept Therapeutics | 3 | $51 |
| Biohaven Pharmaceuticals, Inc. | 1 | $51 |
| Merck | 2 | $41 |
| Boston Scientific | 2 | $41 |
| Tris Pharma Inc | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Novartis | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $21 |
| Insulet Corporation | 1 | $21 |
| Abbott | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,074 in reported general payments places this provider in the 90th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 33 | $40,345 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 18 | $29,624 |
| TrulicityDulaglutide | 18 | $27,495 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 21 | $24,650 |
| Xigduo XrDapaglifloz Propaned/Metformin | 30 | $23,915 |
| RybelsusSemaglutide | 18 | $23,832 |
| EliquisApixaban | 40 | $23,360 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 32 | $18,119 |
| FarxigaDapagliflozin Propanediol | 12 | $8,792 |
| Levothyroxine Sodium | 367 | $4,798 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $4,248 |
| Rosuvastatin Calcium | 235 | $3,845 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 85 | $3,271 |
| Omeprazole | 171 | $3,053 |
| Irbesartan-HydrochlorothiazideIrbesartan/Hydrochlorothiazide | 125 | $3,036 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr | $216 | $64,99554 claims |
| MerckJanumet Xr | $41 | $29,62418 claims |
| Lilly USA, LLCTrulicity | $267 | $27,49518 claims |
| Novo NordiskRybelsus | $808 | $23,83218 claims |
| PfizerEliquis | $477 | $23,36040 claims |
| GSKAnoro Ellipta | $273 | $18,11932 claims |
| AstraZenecaFarxiga, Symbicort | $810 | $13,04027 claims |
| AbbVieSynthroid | $166 | $1,65217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,828 adult health providers in New York.
Other adult health in Penn Yan
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.